Polaris Group, together with its subsidiaries, offers biotechnology, pharmaceutical testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It also offers healthcare consulting, staffing, and MDS solutions. The company was incorporated in 2006 and is based in Grand Cayman, Cayman Islands.
Frequently asked questions
What sector does Polaris Group (6550) operate in?
Polaris Group belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Polaris Group (6550) current stock price?
As of the latest data, Polaris Group stock price is NT$11.10, with a previous close of NT$11.10.
What is Polaris Group (6550) current market capitalization?
Polaris Group market cap is approximately 9.93 billion.
What is Polaris Group (6550) Earnings Per Share (EPS)?
The trailing EPS is -NT$4.88.
What is Polaris Group (6550) EBITDA?
Polaris Group EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -461.54 million.
Does Polaris Group (6550) pay dividends?
No. Polaris Group does not pay a dividend.
What is Polaris Group (6550) beta (volatility) score?
Polaris Group has a beta of 0.598, indicating lower volatility than the overall market.